Announcement

Collapse
No announcement yet.

NEJM - Amantadine accelerated recovery in patients with severe traumatic brain injury

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • NEJM - Amantadine accelerated recovery in patients with severe traumatic brain injury

    Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain Injury

    Joseph T. Giacino, Ph.D., John Whyte, M.D., Ph.D., Emilia Bagiella, Ph.D., Kathleen Kalmar, Ph.D., Nancy Childs, M.D., Allen Khademi, M.D., Bernd Eifert, M.D., David Long, M.D., Douglas I. Katz, M.D., Sooja Cho, M.D., Stuart A. Yablon, M.D., Marianne Luther, M.D., Flora M. Hammond, M.D., Annette Nordenbo, M.D., Paul Novak, O.T.R., Walt Mercer, Ph.D., Petra Maurer-Karattup, Dr.Rer.Nat., and Mark Sherer, Ph.D.
    N Engl J Med 2012; 366:819-826March 1, 2012

    snip


    CONCLUSIONS
    Amantadine accelerated the pace of functional recovery during active treatment in patients with post-traumatic disorders of consciousness. (Funded by the National Institute on Disability and Rehabilitation Research; ClinicalTrials.gov number, NCT00970944.)

Working...
X